24 studies found for:    Open Studies | Type 1 Diabetes | Denmark
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Study of Dapagliflozin in Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Dapagliflozin;   Drug: Placebo for Dapagliflozin
2 Recruiting The Lira Pump Trial
Condition: Type 1 Diabetes
Interventions: Drug: Liraglutide;   Drug: Placebo
3 Recruiting Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
Conditions: Preeclampsia;   Type 1 Diabetes
Intervention:
4 Recruiting Liraglutide in Newly Onset Type 1 Diabetes.
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Liraglutide
5 Recruiting Treatment of Diabetic Neuropathy With Liraglutide
Conditions: Diabetes Mellitus, Type 1;   Type 1 Diabetes Mellitus
Interventions: Drug: Placebo treatment;   Drug: Liraglutide treatment
6 Recruiting Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy;   Hereditary Axonal Neuropathy;   Hereditary Demyelinated Neuropathy;   Polyneuropathy, Inflammatory Demyelinating, Chronic
Intervention:
7 Not yet recruiting DiaCon Dual-Hormone Closed-Loop Glucose Control
Condition: Type 1 Diabetes
Interventions: Device: DiaCon dual-hormone closed-loop glucose control algorithm;   Device: DiaCon single-hormone closed-loop glucose control algorithm
8 Recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
9 Not yet recruiting Acute Exercise and Glucotoxicity
Conditions: Type 1 Diabetes;   Type 2 Diabetes
Interventions: Behavioral: Exercise;   Procedure: Hyperglycemia
10 Recruiting User Evaluation of the MiniMed 620G and 640G Insulin Pumps
Conditions: Type 1 Diabetes;   Type 2 Diabetes
Intervention: Device: Medtronic MiniMed 620G or 640G Insulin Pump
11 Not yet recruiting Volumetric Measurements of Diabetic Foot Ulcers
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Foot
Intervention: Device: 3D photooptical camera
12 Recruiting Diameter Changes of Retinal Vessels During Hypoxia
Conditions: Diabetes Mellitus Type 1;   Diabetic Maculopathy
Interventions: Other: COX inhibitor;   Other: L-NG-monomethyl arginine citrate;   Other: COX inhibitor + L-NG-monomethyl arginine citrate
13 Recruiting Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
Conditions: Diabetes Mellitus Type I;   Ketoacidosis
Interventions: Drug: Insulin withdrawal;   Drug: Norditropin
14 Unknown  Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4
Conditions: Diabetes Mellitus Type I;   Diabetes Mellitus Type II
Intervention: Device: Integrated sensor and infusion set.
15 Unknown  GIP and GLP-1 in Type 1 Diabetes
Condition: Hypoglycemia
Interventions: Other: GIP;   Other: GLP-1;   Other: Saline
16 Recruiting A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
Conditions: Diabetic Nephropathies;   Coronary Artery Disease
Interventions: Drug: Allopurinol;   Drug: Placebo
17 Recruiting IL-1RA, Acute Exercise, and Beta-cell Function
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Anakinra (AN);   Behavioral: Exercise (EX);   Behavioral: Control (CON)
18 Recruiting Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Sevelamer;   Drug: Cholecystokinin;   Drug: Sevelamer placebo;   Drug: Isotonic saline
19 Unknown  The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia
Condition: Type 2 Diabetes
Interventions: Procedure: Double-balloon enteroscopy;   Other: Standard meal test
20 Unknown  The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects
Condition: Type 2 Diabetes
Intervention: Other: Exendin 9-39 (Bachem, Germany)

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years